165 related articles for article (PubMed ID: 33380658)
1. Antiangiogenic activity of zinc and zinc-sorafenib combination using the chick chorioallantoic membrane assay: A descriptive study.
Kumar M; Meshram GG; Rastogi T; Sharma S; Gupta R; Jain S; Prasad A; Galav V; Bhattacharya SK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S84-S89. PubMed ID: 33380658
[TBL] [Abstract][Full Text] [Related]
2. An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane.
Nawara HM; Afify SM; Hassan G; Zahra MH; Atallah MN; Seno A; Seno M
Cell Biol Int; 2021 Apr; 45(4):749-756. PubMed ID: 33274828
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antiangiogenic and antiproliferative potential of ethanolic extracts of
Muralidharan K; Kumaravelu P; David DC
J Cancer Res Ther; 2021; 17(2):484-490. PubMed ID: 34121696
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer.
Devapatla B; Sharma A; Woo S
PLoS One; 2015; 10(9):e0139237. PubMed ID: 26414070
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis.
Khater M; Greco F; Osborn HMI
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066630
[No Abstract] [Full Text] [Related]
6. Antiangiogenic effect of heparin and other sulphated glycosaminoglycans in the chick embryo chorioallantoic membrane.
Jakobson AM; Hahnenberger R
Pharmacol Toxicol; 1991 Aug; 69(2):122-6. PubMed ID: 1723204
[TBL] [Abstract][Full Text] [Related]
7. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
Tufan AC; Satiroglu-Tufan NL
Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
[TBL] [Abstract][Full Text] [Related]
8. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
[TBL] [Abstract][Full Text] [Related]
9. IKOSA
Annese T; Tamma R; Ribatti D
Methods Mol Biol; 2023; 2572():129-139. PubMed ID: 36161413
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine Used in Combination with Chemotherapy Synergistically Suppresses Growth and Angiogenesis
Gurel-Gurevin E; Kiyan HT; Esener OBB; Aydinlik S; Uvez A; Ulukaya E; Dimas K; Armutak EI
Anticancer Res; 2018 Jul; 38(7):4011-4020. PubMed ID: 29970525
[TBL] [Abstract][Full Text] [Related]
11. The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
Ribatti D
Rom J Morphol Embryol; 2008; 49(2):131-5. PubMed ID: 18516317
[TBL] [Abstract][Full Text] [Related]
12. In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin.
Ribatti D; Nico B; Mangieri D; Longo V; Sansonno D; Vacca A; Dammacco F
Histol Histopathol; 2007 Mar; 22(3):285-9. PubMed ID: 17163402
[TBL] [Abstract][Full Text] [Related]
13. A novel four-step system for screening angiogenesis inhibitors.
Zhou Q; Qi CL; Li Y; He XD; Li JC; Zhang QQ; Tian L; Zhang M; Han Z; Wang H; Yang X; Wang LJ
Mol Med Rep; 2013 Dec; 8(6):1734-40. PubMed ID: 24068303
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Pircher A; Jöhrer K; Kocher F; Steiner N; Graziadei I; Heidegger I; Pichler R; Leonhartsberger N; Kremser C; Kern J; Untergasser G; Gunsilius E; Hilbe W
Oncotarget; 2016 Apr; 7(15):20109-23. PubMed ID: 26956051
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic Activity of Quinine Alone and in Combination with vitamin C in both ex vivo and in vivo Assays.
Jalil ZH; Sahib HB
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4185-4192. PubMed ID: 36580001
[TBL] [Abstract][Full Text] [Related]
17. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.
Ribatti D
Int Rev Cell Mol Biol; 2008; 270():181-224. PubMed ID: 19081537
[TBL] [Abstract][Full Text] [Related]
18. Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.
Martin B; Edeline J; Patard JJ; Oger E; Jouan F; Boulanger G; Zerrouki S; Vigneau C; Rioux-Leclercq N
J Cancer Res Clin Oncol; 2012 Jun; 138(6):907-16. PubMed ID: 22322364
[TBL] [Abstract][Full Text] [Related]
19. The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.
Ribatti D; Tamma R
J Cell Physiol; 2018 Jan; 234(1):152-157. PubMed ID: 30078179
[TBL] [Abstract][Full Text] [Related]
20. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances.
Hazel SJ
J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
